2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Gemcitabine (Gem) is an effective anticancer drug used for the treatment of various cancers. Nevertheless, its clinical benefit is limited owing to its very short plasma half-life, rapid enzymatic inactivation, and systemic toxicity. Here, we report the design, synthesis, and comprehensive biological evaluation of four...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
